LR Health & Beauty SE grows profitably in the first quarter 2025
Sales increased by 2.0% to EUR 74.0 million in the first quarter
EBITDA reported significantly improved by 20.5% to EUR 7.4 million
Digitalization and process optimization in logistics & IT increase efficiency
Forecast for the financial year 2025 confirmed
LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, recently published its figures for the first quarter of 2025.
In the first three months of the financial year 2025, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 74.0 million (Q1 2024: EUR 72.6 million). Despite the generally subdued consumer sentiment in Europe, the company was able to increase sales by 2.0% compared to the first quarter of the previous year.
Furthermore, EBITDA reported amounted to EUR 7.4 million (Q1 2024: EUR 6.1 million) in the first quarter of 2025, which corresponds to a significant increase of 20.5% compared to the same period of the previous year. On the one hand, both the sales growth achieved, and overall stable cost structures had a positive effect.
On the other hand, one-off extraordinary effects due to the premature refinancing of the old bond burdened the EBITDA reported